IR
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Disclosure
Total of 10posts
| Number | Title | Person with Duty to Submit | Receipt Date |
|---|---|---|---|
| 10 | Lawsuit (Charging More Than Certain Amount) | 2025-06-04 | |
| 9 | Designation as Investment Alert Issue | 2025-05-27 | |
| 8 | Lawsuit (Charging More Than Certain Amount) | 2025-05-23 | |
| 7 | Subscription Right Newly listed(셀리드 13R) | KOSDAQ STOCK MKT. | 2025-05-23 |
| 6 | Advance notice for assignment of issue for abnormal rise | 2025-05-22 | |
| 5 | (Forewarning) Designation as Temporary Overheated Issue(3 day- Periodic Call Auction Trading) | KOSDAQ STOCK MKT. | 2025-05-22 |
| 4 | [Investment Caution] Issue traded by linked accounts with high market influence | 2025-05-08 | |
| 3 | Ex-Rights(유상증자) | KOSDAQ STOCK MKT. | 2025-05-02 |
| 2 | [Revised]Decision on Paid-in Capital Increase | 2025-05-02 | |
| 1 | Initial (Tentative) Issue Price of Rights Offering | 2025-05-02 |
